Cargando…

Tumor-binding antibodies and tumor immunity

Detalles Bibliográficos
Autores principales:	Carmi, Yaron, Engleman, Edgar G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742082/ https://www.ncbi.nlm.nih.gov/pubmed/26457878

Ejemplares similares

Tumor-reactive T cells are licensed by dendritic cells located in spatially different tissues: implications for dendritic cell vaccines
por: Santana-Magal, Nadine, et al.
Publicado: (2021)

Allogeneic IgG combined with dendritic cell stimuli induces anti-tumor T cell immunity
por: Carmi, Yaron, et al.
Publicado: (2015)

Antibody Repertoire Analysis of Tumor-Infiltrating B Cells Reveals Distinct Signatures and Distributions Across Tissues
por: Aizik, Ligal, et al.
Publicado: (2021)

The role IL-1 in tumor-mediated angiogenesis
por: Voronov, Elena, et al.
Publicado: (2014)

Fc-binding antibody-recruiting molecules exploit endogenous antibodies for anti-tumor immune responses
por: Sasaki, Koichi, et al.
Publicado: (2020)

Radiation holidays stimulate tumor immunity
por: Surace, Laura, et al.
Publicado: (2015)

Endogenous immunity at the forefront of tumor dormancy
por: Baxevanis, Constantin N, et al.
Publicado: (2015)

Necroptosis DAMPens anti-tumor immunity
por: Shibata, K, et al.
Publicado: (2016)

In vivo selection of tumor-specific antibodies
por: Sánchez-Martín, David, et al.
Publicado: (2013)

Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity
por: Liu, Zhaoshan, et al.
Publicado: (2023)

RUNX3 methylation and anti-tumor immunity
por: Menheniott, Trevelyan R., et al.
Publicado: (2015)

Targeting the tumor-stromal-immune cell axis
por: Gururajan, Murali, et al.
Publicado: (2015)

Tumor Escape and Progression under Immune Pressure
por: Manjili, Masoud H., et al.
Publicado: (2012)

Mouse models to decipher anti-tumor immunity
por: Parigger, Thomas, et al.
Publicado: (2019)

The Role of Hypoxia and the Immune System in Tumor Radioresistance
por: Span, Paul N., et al.
Publicado: (2019)

Human Regulatory Dendritic Cells Develop From Monocytes in Response to Signals From Regulatory and Helper T Cells
por: Zhang, Xiangyue, et al.
Publicado: (2020)

Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors
por: Saba, Nabil F., et al.
Publicado: (2012)

Multiplex imaging reveals the architecture of the tumor immune microenvironment
por: Zhang, Junlei, et al.
Publicado: (2021)

Editorial: ‘Engineering the Tumor Immune Microenvironment’ Special Issue
por: Ahmad, Raffae N., et al.
Publicado: (2023)

Mechanism and effects of extramedullary hematopoiesis on anti-tumor immunity
por: Chen, Zefang, et al.
Publicado: (2023)

Targeting tumor cells with antibodies enhances anti-tumor immunity
por: Sun, Zhichen, et al.
Publicado: (2018)

Modeling the dynamics of antibody–target binding in living tumors
por: Tang, Yu, et al.
Publicado: (2020)

Editorial to Radiation in Multimodal Tumor Immune Therapies—Mechanisms and Application
por: Frey, Benjamin, et al.
Publicado: (2021)

(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas
por: Richardson, Leland G., et al.
Publicado: (2019)

Hypothesis: The Intratumoral Immune Response against a Cancer Progenitor Cell Impacts the Development of Well-Differentiated versus Dedifferentiated Disease in Liposarcoma
por: Tseng, William W., et al.
Publicado: (2016)

Tumor immune microenvironment characterization and response to anti-PD-1 therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2015)

Special Issue on Immune Responses in Tumors and Non-Transformed Inflammatory Microenvironments
por: Jewett, Anahid
Publicado: (2012)

Immune Regulatory Cells in Inflammation, Infection, Tumor, Metabolism, and Other Diseases
por: Guan, Qingdong, et al.
Publicado: (2018)

Tumor mutational burden and immune signatures interplay in renal cell carcinoma
por: Yakirevich, Evgeny, et al.
Publicado: (2020)

Epigenetic modulation of the tumor immune microenvironment by nanoinducers to potentiate cancer immunotherapy
por: Zhang, Ning, et al.
Publicado: (2022)

Galectins: Their Network and Roles in Infection/Immunity/Tumor Growth Control 2021
por: Hattori, Toshio
Publicado: (2022)

Unique Versus Redundant Functions of IL-1α and IL-1β in the Tumor Microenvironment
por: Voronov, Elena, et al.
Publicado: (2013)

Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations
por: Rider, Peleg, et al.
Publicado: (2016)

Editorial: Implementing Logic Gates in Adoptive Cell Therapy
por: Gross, Gideon, et al.
Publicado: (2022)

The Role of HLA-Class Ib Molecules in Immune-Related Diseases, Tumors, and Infections
por: Morandi, Fabio, et al.
Publicado: (2014)

Immune Regulatory Cells in Inflammation, Infection, Tumor, Metabolism, and Other Diseases 2019
por: Guan, Qingdong, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors in the Pre-operative Setting and Impact on the Primary Renal Tumor
por: Gulati, Shuchi, et al.
Publicado: (2022)

New Roles for Old Friends: Involvement of the Innate Immune System in Tumor Progression
por: Castaño, María, et al.
Publicado: (2023)

Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2021)

Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapy
por: Liu, Hongchuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_of3sq4hqnojvefeih8pjeutdsg